Telemonitoring and Teleintervention of Heart Failure and Decrease of Non-fatal Events. (ICOR)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01495078|
Recruitment Status : Completed
First Posted : December 19, 2011
Last Update Posted : February 17, 2016
|Condition or disease||Intervention/treatment||Phase|
|Heart Failure||Procedure: Telemonitoring||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||178 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Telemonitoring and Teleintervention of Heart Failure and Decrease of Non-fatal Events.|
|Study Start Date :||December 2010|
|Actual Primary Completion Date :||June 2013|
|Actual Study Completion Date :||December 2014|
Patients with follow-up telemonitoring
Is a computer system designed jointly by engineers and clinical personal of Parc Salut Mar) to be able daily automated selfreported symptom and weight, blood pressure and heart rate monitoring . The system allow weekly follow up throught videoconferences.
Information from the telemonitoring system is automatically downloaded to a secure Internet site for review by clinicians and nurses.
No Intervention: Non - telemonitoring
Patients with usual face follow-up
- Non fatal events [ Time Frame: Six months after inclusion of the patient. ]Non fatal events are defined as an event of descompensation requiring either parenteral treatment as outpatients in a day hospital an in the emergency department or by income.
- Morbid mortality [ Time Frame: From telemonitoring (baseline) until six months later ]
- Hospital readmission [ Time Frame: From telemonitoring (baseline) until six months later ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01495078
|Parc de Salut Mar|
|Barcelona, Spain, 08003|
|Principal Investigator:||JOSEP COMIN COLET, MD||HOSPITAL DEL MAR MEDICAL RESEARCH INSTITUTE|